Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $7.1200 (-3.78%) ($7.0400 - $7.2800) on Fri. Sep. 20, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.19% (three month average) | RSI | 68 | Latest Price | $7.1200(-3.78%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EYES advances 5.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) UNG(7%) IGOV(6%) ICLN(5%) FIVG(4%) | Factors Impacting EYES price | EYES will decline at least -1.595% in a week (0% probabilities). BND(-8%) XLP(-6%) XLK(-6%) VCIT(-6%) SLV(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.595% (StdDev 3.19%) | Hourly BBV | 0 () | Intraday Trend | -1.2% | | | |
|
5 Day Moving Average | $7.19(-0.97%) | 10 Day Moving Average | $7.02(1.42%) | 20 Day Moving Average | $6.64(7.23%) | To recent high | -7.3% | To recent low | 21.9% | Market Cap | $2.274b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |